skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Zhao, Yan remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
基于HMGB1/NF-κB/NLRP3轴探讨褪黑素对氧诱导视网膜病变的保护作用
基于HMGB1/NF-κB/NLRP3轴探讨褪黑素对氧诱导视网膜病变的保护作用
Material Type:
Artigo 		Adicionar ao Meu Espaço

基于HMGB1/NF-κB/NLRP3轴探讨褪黑素对氧诱导视网膜病变的保护作用

褚芳芳 ; 赵岩松 ; 赵玉泽 ; 白晨 ; 肖培伦 ; 王晓莉 ; 于树娜 ; 蒋吉英

中国当代儿科杂志, 2023, Vol.25 (6), p.645-652

潍坊医学院人体解剖学教研室,山东潍坊 261053%潍坊医学院附属医院眼科中心,山东潍坊 261031%潍坊医学院医学影像学院,山东潍坊 261053

Texto completo disponível

Citações Citado por
2
N-acetylserotonin alleviates retinal ischemia-reperfusion injury via HMGB1/RAGE/NF-κB pathway in rats
N-acetylserotonin alleviates retinal ischemia-reperfusion injury via HMGB1/RAGE/NF-κB pathway in rats
Material Type:
Artigo 		Adicionar ao Meu Espaço

N-acetylserotonin alleviates retinal ischemia-reperfusion injury via HMGB1/RAGE/NF-κB pathway in rats

Zhao, Yu-Ze ; Zhang, Xue-Ning ; Yin, Yi ; Xiao, Pei-Lun ; Gao, Meng ; Zhang, Lu-Ming ; Zhou, Shuan-Hu ; Yu, Shu-Na ; Wang, Xiao-Li ; Zhao, Yan-Song

International journal of ophthalmology, 2024-02, Vol.17 (2), p.228-238 [Periódico revisado por pares]

China: International Journal of Ophthalmology Press

Texto completo disponível

Citações Citado por
3
Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma

Wang, Hai-Ying ; Yao, Zhi-Hua ; Tang, Hong ; Zhao, Yan ; Zhang, Xiao-San ; Yao, Shu-Na ; Yang, Shu-Jun ; Liu, Yan-Yan

OncoTargets and therapy, 2016-01, Vol.9, p.5663-5669 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
4
A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma
A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma

Wang, Hai-Ying ; Yao, Zhi-Hua ; Tang, Hong ; Zhao, Yan ; Jin, Shui-Ling ; Zhou, Wen-Ping ; Yao, Shu-Na ; Yang, Shu-Jun ; Liu, Yan-Yan ; Luo, Su-Xia

Oncotarget, 2017-01, Vol.8 (5), p.7540-7547

United States: Impact Journals LLC

Texto completo disponível

Citações Citado por
5
p63 expression is a prognostic factor in colorectal cancer
p63 expression is a prognostic factor in colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

p63 expression is a prognostic factor in colorectal cancer

Guo, Hong-Qiang ; Huang, Guo-Liang ; Liu, Ou-Fei ; Liu, Yan-Yan ; Yao, Zhi-Hua ; Yao, Shu-Na ; Zhao, Yan ; Liu, Tao ; Pu, Xing-Xiang ; Lin, Tong-Yu ; Yang, Shu-Jun

The International journal of biological markers, 2012-07, Vol.27 (3), p.212-218 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
6
PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma
PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma

Liu, Yan-Yan ; Yao, Shu-Na ; Zhao, Yan ; Yao, Zhi-Hua ; MA, Jie ; Xia, Qing-Xin ; Fu, Kai ; Yang, Shu-Jun

Leukemia & lymphoma, 2010-09, Vol.51 (9), p.1692-1698 [Periódico revisado por pares]

United States: Informa Healthcare

Texto completo disponível

Citações Citado por
7
Inhibitory effects of celecoxib combined with capecitabine on H22 hepatoma mice and its mechanism
Inhibitory effects of celecoxib combined with capecitabine on H22 hepatoma mice and its mechanism
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibitory effects of celecoxib combined with capecitabine on H22 hepatoma mice and its mechanism

Yao, Zhi-hua ; Yuan, Ya-dong ; Liu, Yan-yan ; Guo, Hong-qiang ; Zhao, Yan ; Yao, Shu-na ; Yang, Shu-jun

Zhōngguó yīxué kēxuéyuàn xuébào, 2013-08, Vol.35 (4), p.447-450 [Periódico revisado por pares]

China

Texto completo disponível

Citações Citado por
8
Metrnl regulates cognitive dysfunction and hippocampal BDNF levels in D-galactose-induced aging mice
Metrnl regulates cognitive dysfunction and hippocampal BDNF levels in D-galactose-induced aging mice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metrnl regulates cognitive dysfunction and hippocampal BDNF levels in D-galactose-induced aging mice

Hong, Chen ; Wang, Zhi ; Zheng, Si-Li ; Hu, Wen-Jun ; Wang, Shu-Na ; Zhao, Yan ; Miao, Chao-Yu

Acta pharmacologica Sinica, 2023-04, Vol.44 (4), p.741-751 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (6)

Data de Publicação 

De até
Refinar
  1. Antes de2010  (1)
  2. 2010Até2011  (1)
  3. 2012Até2012  (1)
  4. 2013Até2016  (2)
  5. Após 2016  (4)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (6)
  2. Chinês  (2)
  3. Japonês  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.